IL18RAP and neoplasm: NK cells, CD8+ T cells, and M1 macrophages are key to the killing of tumor cells in vivo [28, 29], and our analysis revealed that IL18RAP can promote CD8+ T cells and M1 macrophages infiltration in various cancers.